Resources
Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.
Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.
Found 43 Results
Prospective real-world study on the utility of PhasED-Seq MRD – Dr. Brian Sworder, ASH 2023
January 31, 2024 | Video
Optimizing ctDNA limits of detection for DLBCL during 1L therapy – Dr. Jordan Goldstein, ASH 2023
January 31, 2024 | Video
PhasED-Seq as an early outcome predictor for liso-cel therapy in DLBCL – Dr. Ash Alizadeh, ASH 2023
January 31, 2024 | Video
Improving MRD assessment and response criteria in DLBCL: insights into PhasED-Seq
January 25, 2024 | Video
Landmark comparison of PhasED-Seq ctDNA vs. singular PET/CT scan – Dr. Mark Roschewski, ASH 2023
January 25, 2024 | Video
Where is MRD headed, signals from the 2024 JP Morgan Healthcare Conference
January 25, 2024 | Blog Post